The Quantgene Mission
Total Protection of Your Health
Quantgene has developed the world’s first single-molecule, cell-free DNA (cfDNA) sequencing platform to investigate the mutational landscape of your blood with unprecedented accuracy. It can provide deep information about a broad range of clinical conditions, including cancer, at earlier stages than conventional methods. Our proprietary technology is leading the way into the future of medicine: a world in which key diseases are detected and effectively treated well before they become life-threatening.